WHO ICTRP trial
Erythropoietin in Traumatic Brain Injury (EPO-TBI)
ACTRN12609000827235 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12609000827235 |
|---|---|
| Public title | Erythropoietin in Traumatic Brain Injury (EPO-TBI) |
| Scientific title | A randomised, placebo-controlled trial evaluating the effect of erythropoietin on neurological function in intensive care unit (ICU) patients with traumatic brain injury |
| Primary sponsor | Australian and New Zealand Intensive Care Research Centre |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia;New Zealand;New Zealand;New Zealand;Saudi Arabia;New Zealand |
| Conditions | Moderate traumatic brain injury;Severe traumatic brain injury; Moderate traumatic brain injury Severe traumatic brain injury;Injuries and Accidents - Other injuries and accidents |
| Interventions | Epoetin alfa (rch) 40,000 units, volume of 1mililitre, given as a subcutaneous injection weekly for up to 3 doses. |
| Registration date | Sep 22, 2009 |
| Target size | 606 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: